Sign-in to Ask A Doctor - 24x7
OR
Sign in with Google
Suggest Treatment Plan For Relapse Of Follicular Leukemia
Question: Transformed FL (follicular Leukemia) is characterized by What?
FL patient NW experienced a CR (Complete Recovery) following primary treatment with CVP+rituximab but relapsed 4 months later. Which of the following therapies is indicated for patients with NW's characteristics?
A. fludarabine + alemtozamab
B. 90Y intumomab or 131I tostomumab
C. fludaarbine + rituximab
D. Rituximab + CHOP
Which prophylactic treatment are recommended for CLL patent treated with flurdarabine or rituximab? Why?
A. Patients should be given predrisone or dexamethasone to minimize the effects of tumor lysis syndrome.
B. Patients should be given predrisone or dexamethasone to minimize the effect od uremic-hemolytic syndrome.
C. Patients should be hydrated and given allopurinol or rasburicase to minimize the effects of uremic-hemplytic
D. Patients should be hydrated and given allopurinol or rasburicase to minimize the effects of tumor lysis syndrome
FL patient NW experienced a CR (Complete Recovery) following primary treatment with CVP+rituximab but relapsed 4 months later. Which of the following therapies is indicated for patients with NW's characteristics?
A. fludarabine + alemtozamab
B. 90Y intumomab or 131I tostomumab
C. fludaarbine + rituximab
D. Rituximab + CHOP
Which prophylactic treatment are recommended for CLL patent treated with flurdarabine or rituximab? Why?
A. Patients should be given predrisone or dexamethasone to minimize the effects of tumor lysis syndrome.
B. Patients should be given predrisone or dexamethasone to minimize the effect od uremic-hemolytic syndrome.
C. Patients should be hydrated and given allopurinol or rasburicase to minimize the effects of uremic-hemplytic
D. Patients should be hydrated and given allopurinol or rasburicase to minimize the effects of tumor lysis syndrome
Brief Answer:
Rituximab + CHOP
Detailed Answer:
Hi
Since the patient had relapse of follicular Leukemia after 4 months he will mow need treatment with targeted therapy such as Rituximab with CHOP chemotherapy which consist of the folllowing drugs cyclophosphamide, doxorubicin, vincristine and prednisone.
Re treatment responses with Rituximab appear to be longer than the patients’ initial responses with the drug.
Regards
DR De
Rituximab + CHOP
Detailed Answer:
Hi
Since the patient had relapse of follicular Leukemia after 4 months he will mow need treatment with targeted therapy such as Rituximab with CHOP chemotherapy which consist of the folllowing drugs cyclophosphamide, doxorubicin, vincristine and prednisone.
Re treatment responses with Rituximab appear to be longer than the patients’ initial responses with the drug.
Regards
DR De
Note: For further queries related to kidney problems Click here.
Above answer was peer-reviewed by :
Dr. Shanthi.E
Answered by
Get personalised answers from verified doctor in minutes across 80+ specialties
